"10.1371_journal.pone.0096697","plos one","2014-05-09T00:00:00Z","Qi Zhao; Pui-Fan Wong; Susanna S T Lee; Shui-On Leung; Wing-Tai Cheung; Jun-Zhi Wang","School of Biomedical Sciences, The Chinese University of Hong Kong, Shatin, Hong Kong, China; Institute of Biomedical Sciences, Fudan University, Shanghai, China; School of Life Sciences, The Chinese University of Hong Kong, Shatin, Hong Kong, China; National Institutes for Food and Drug Control, Beijing, China","Conceived and designed the experiments: SSTL SOL WTC JZW. Performed the experiments: QZ PFW. Analyzed the data: QZ SOL JZW WTC. Contributed reagents/materials/analysis tools: SSTL SOL WTC. Wrote the paper: QZ SOL WTC.","The authors would like to declare that all authors except SOL have no competing interests. SOL is one of the co-founders of SinoMed Biosciences Ltd. At the present moment, no product relating to anti-idiotype anti-CD22 is in development. Neither any direct or indirect interests, nor funding, consultancy, or employment is provided by SinoMed or other companies for commercial-related purpose and activities. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.","2014","05","Qi Zhao","QZ",6,FALSE,4,2,4,3,TRUE,TRUE,FALSE,0,NA,FALSE
